Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Patterns, Medication Usage, Effectiveness, and Safety Among US Veterans Using the Remote Electrical Neuromodulation (REN) Wearable Device for Migraine Treatment

NCT07336420 is registered in ClinicalTrials.gov with Theranica as lead sponsor.

NCT NCT07336420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07336420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Patterns, Medication Usage, Effectiveness, and Safety Among US Veterans Using the Remote Electrical Neuromodulation (REN) Wearable Device for Migraine Treatment
Lead sponsor
Theranica
Phase
Phase 4
Overall status
Completed
Start date
January 9, 2026
Completion date
January 30, 2026
Enrollment
466 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute treatment of migraine, migraine